# Ketamine / Propofol Admixture "Ketofol" at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial

> **NCT02105415** · PHASE2,PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 160 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Ketamine / Propofol Admixture
- **DRUG:** Etomidate

## Key facts

- **NCT ID:** NCT02105415
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-11-28
- **Final completion:** 2018-08-01
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02105415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02105415, "Ketamine / Propofol Admixture "Ketofol" at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02105415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*